Emerging drugs for partial-onset epilepsy: a review of brivaracetam
Lan Gao,1 Shuchuen Li2 1Deakin Population Health SRC, Faculty of Health, Deakin University, Burwood, Victoria, 2School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia Abstract: There are more than 12 new antiepileptic drugs approved in the last 2 decades....
Saved in:
Main Authors: | Gao L (Author), Li SC (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New developments in the management of partial-onset epilepsy: role of brivaracetam
by: Coppola G, et al.
Published: (2017) -
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures
by: Mumoli L, et al.
Published: (2015) -
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures [Corrigendum]
by: Mumoli L, et al.
Published: (2015) -
Α Multicenter Retrospective Study Evaluating Brivaracetam in the Treatment of Epilepsies in Clinical Practice
by: Maria Stefanatou, et al.
Published: (2021) -
A review of the pharmacology and clinical efficacy of brivaracetam
by: Klein P, et al.
Published: (2018)